Bio-Techne Corporation
TECH
Peringkat dalam Saham
#1871
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Harga Saham
$72.49
Kapitalisasi Pasar
$11.37B
Perubahan (1 hari)
-0.12%
Perubahan (1 tahun)
17.18%
Negara
US
Perdagangan Bio-Techne Corporation (TECH)
Kategori
Healthcare
Rasio P/E untuk Bio-Techne Corporation (TECH)
Rasio P/E per October 2026 TTM: 61.97
Menurut laporan keuangan dan harga saham terbaru dari Bio-Techne Corporation, rasio P/E saat ini (TTM) adalah 61.97. Pada akhir 2024, perusahaan memiliki rasio P/E sebesar 67.18.
Riwayat rasio P/E untuk Bio-Techne Corporation dari 2000 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 61.97 | -43.88% |
| 2025 | 110.41 | 64.35% |
| 2024 | 67.18 | 49.36% |
| 2023 | 44.98 | -9.99% |
| 2022 | 49.97 | -59.78% |
| 2021 | 124.26 | 182.43% |
| 2020 | 44.00 | -46.54% |
| 2019 | 82.30 | 86.05% |
| 2018 | 44.24 | -22.03% |
| 2017 | 56.74 | 41.34% |
| 2016 | 40.14 | 18.38% |
| 2015 | 33.91 | 10.18% |
| 2014 | 30.78 | 34.96% |
| 2013 | 22.80 | -6.55% |
| 2012 | 24.40 | -11.39% |
| 2011 | 27.54 | 41.26% |
| 2010 | 19.49 | -14.94% |
| 2009 | 22.92 | -21.66% |
| 2008 | 29.25 | 10.46% |
| 2007 | 26.48 | -2.30% |
| 2006 | 27.11 | -3.27% |
| 2005 | 28.02 | -16.81% |
| 2004 | 33.69 | 21.76% |
| 2003 | 27.67 | -35.05% |
| 2002 | 42.59 | 7.61% |
| 2001 | 39.58 | -60.15% |
| 2000 | 99.34 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 28.78 | -53.55% |
US
|
|
| -28.36 | -145.76% |
US
|
|
| -24.57 | -139.65% |
AU
|
|
| - | - |
CH
|
|
| 30.33 | -51.05% |
NL
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.